SMO Sarah Cannon Research Inst.

Nashville, Tennessee 37203

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Breast Neoplasms Clinical Trial
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials